Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis

BACKGROUND: Adherence to disease-modifying therapies is determinant to attain maximal clinical benefit in multiple sclerosis (MS). RebiSmart® is an electronic auto-injector for subcutaneous delivery of interferon β-1a (INF-β1a) that monitors adherence by featuring a log of each drug administration f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauri-Suárez, Sergio, Quiñones-Aguilar, Sandra, Contreras-Marín, Arturo, Ramiro-Guerrero, Erik Omar, Zúñiga-García, David, Salinas-Vázquez, Leticia, Llamas-López, Leonardo, León-Jiménez, Carolina, García-Martell, Adriana, González-Hernández, Iliana, Chiquete, Erwin, García, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170219/
https://www.ncbi.nlm.nih.gov/pubmed/32310950
http://dx.doi.org/10.1371/journal.pone.0230959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170219/
https://www.ncbi.nlm.nih.gov/pubmed/32310950
http://dx.doi.org/10.1371/journal.pone.0230959

Ejemplares similares